Aasebo U, Gyltnes A, Bremnes RM, Aakvaag, A Slordal L (1993) Reversal of sexual impotence in male patients with chronic obstructive pulmonary disease and hypoxemia with long term oxygen therapy. J Steroid Biochem Mol Biol 46:799-803 Adams GE, Dische S, Fowler JF, Thomlinson RH (1976) Hypoxic cell sensitisers in radiotherapy. Lancet 1:186-188

Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall LM, So AG (1983) Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 308:1396-1399 Alexandersen P, Haarbo J, Christiansen C (1996) The relationship of natural androgens to coronary heart disease in male: a review. Atherosclerosis 125:1-13 Aloi JA, Bergendahl M, Iranmanesh A, Veldhuis JD (1997) Pulsatile intravenous gonadotropin-releasing hormone administration averts fasting-induced hypogonadotropism and hypoan-drogenemia in healthy, normal weight men. J Clin Endocrinol Metab 82:1543-1548 Altschule MD, Tillotson KJ (1948) The use of testosterone in the treatment of depressions.

N Engl J Med 239:1036-1038 Ambriz R, Pizzuto J, Morales M, Chavez G, Guillen C, Aviles A (1986) Therapeutic effect of danazol on metrorrhagia in patients with idiopathic thrombocyotpenic purpura (ITP). Nouv Rev Fr Hematol 28:275-279 Amory JK, Chansky HA, Chansky KL, Camuso MR, Hoey CT, Anawalt BD, Matsumoto AM, Bremner WJ (2002) Preoperative supraphysiological testosterone in older men undergoing knee replacement surgery. J Am Geriatr Soc 50:1698-1701

Anderson FH, Francis RM, Peaston RT, Wastell HJ (1997) Androgen supplementation in eugo-nadal men with osteoporosis: effects of six months treatment on bone formation and resorption. J Bone Miner Res 12:472-478 Antus B, Yao Y, Liu S, Song E, Lutz J, Heemann U (2001) Contribution of androgens to chronic allograft nephropathy is mediated by dihydrotestosterone. Kidney Int 60:1955-1963 Antus B, Yao Y, Song E, Liu S, Lutz J, Heemann U (2002) Opposite effects of testosterone and estrogens on chronic allograft nephropathy. Transpl Int 15:494-501 Bacigalupo A, Chaple M, Hows J, Lint MTV, McCann S, Milligan D, Chessells J, Goldstone AH, Ottolander J, Veer ETvt, Comotti B, Coser P, Broccia G, Bosi A, Locasciulli A, Catalano L, Battista R, Arcese W, Carotenuto M, Marmont AM, Gordon Smith EC (1993) Treatment of aplastic anemia (AA) with antilymphocyte globulin (ALG) and methylprednisolone (MPred) with or without androgens: a randomized trial from the EBMT SAA working party. Br J Hematol 83:145-151

Bakhshi V, Elliott M, Gentili A, Godschalk M, Mulligan T (2000) Testosterone improves rehabilitation outcomes in ill older men. J Am Geriatr Soc 48:550-553 Ballal SH, Domoto DT, Polack DC, Marciulonis P, Martin KJ (1991) Androgens potentiate the effects of erythropoietin in the treatment of anemia of end-stage renal disease. Am J Kidney Dis 17:29-33

Barrett-Connor E. Testosterone, HDL-cholesterol and cardiovascular disease. In: Bhasin S, Gabelnick HL, Spieler JM, Swerdloff RS, Wang C, Kelly C (eds) Pharmacology, biology, and clinical applications of androgens: current status and future prospect. Wiley-Liss, New York, 1996, pp 215-223

Batterham MJ, Garsia R (2001) A comparison of megestrol acetate, nandrolone decanoate and dietary counselling for HIV associated weight loss. Int J Androl 24:232-240 Belch JJ, Madhok R, McArdle B, McLaughlin K, Kluft C, Forbes CD, Sturrock R (1986) The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol. Q J Med 58:19-27 Berger JR, Pall L, Hall CD, Simpson DM (1996) Oxandrolone in AIDS-wasting myopathy. AIDS 10:1657-1662

Berns JS, Rudnick MR, Cohen RM (1992) Acontrolled trial of recombinant human erythropoietin and nandrolone decanoate in the treatment of anemia in patients on chronic hemodialysis. Clin Nephrol 37:264-267 Bex FJ, Corbin A, France E (1982) Resistance of the mouse to the antifertility effects of LHRH

agonists. Life Sci 30:1263-1269 Bhasin S, Storer TW, Asbel-Sethi N, Kilbourne A, Hays R, Sinha-Hikim I, Shen R, Arver S, Beall G (1998) Effects of testosterone replacement with a nongenital, transdermal system, Androderm, in human immunodeficiency-virus-infected men with low testosterone levels. J Clin Endocrinol Metab 83:3155-3162 Bhasin S, Woodhouse L, Casaburi R, Singh AB, Bhasin D, Berman N, Chen X, Yarasheski KE, Magliano L, Dzekov C, Dzekov J, Bross R, Phillips J, Sinha-Hikim I, Shen R, Storer TW (2001) Testosterone dose-response relationships in healthy young men. Am J Physiol Endocrinol Metab 281:E1172-1181

Blamey SL, Garden OJ, Shenkin A, Carter DC (1984) Modification of postoperative nitrogen balance with preoperative anabolic steroid. Clin Nutr 2:187-192 Bonkovsky HL, Fiellin DA, Smith GS, Slaker DP, Simon D, Galambos JT (1991) A randomized, controlled trial of treatment of alcoholic hepatitis with parenteral nutrition and oxandrolone. I. Short-term effects on liver function. Am J Gastroenterol 86:1200-1208 Booij A, Biewenga-Booij CM, Huber-Bruning O, Cornelis C, Jacobs JW, Bijlsma JW (1996) Androgens as adjuvant treatment in postmenopausal female patients with rheumatoid arthritis. Ann Rheum Dis 55:811-815 Branda RF, Amsden TW, Jacob HS (1977) Randomized study of nandrolone therapy for anemia due to bone marrow failure. Arch Intern Med 137:65-69 Brennemann W, Brensing KA, Leipner N, Boldt I, Klingmuller D (1994) Attempted protection of spermatogenesis from irradiation in patients with seminoma by D-Tryptophan-6 luteinizing hormone releasing hormone. Clin Invest Med 72:838-842 Brinster RL, Avarbock MR (1994) Germline transmission of donor haplotype following spermatogonia! transplantation. Proc Nat Acad Sci USA 91:11303-11307 Brinster RL, Zimmermann JW (1994) Spermatogenesis following male germ-cell transplantation.

Proc Nat Acad Sci USA 91:11298-11302 Brubaker LH, Briere J, Laszlo J, Kraut E, Landaw SA, Peterson P, Goldberg J, Donovan P (1982) Treatment of anemia in myeloproliferative disorders: a randomized study of fluoxymesterone v transfusions only. Arch Intern Med 142:1533-1537 Buchwald D, Argyres S, Easterling RE, Jr FJO, Brewer GJ, Schoomaker EB, Abbrecht PH, Williams GW, Weller JM (1977) Effect of nandrolone decanoate on the anemia of chronic hemodialysis patients. Nephron 18:232-238 Camitta BM, Thomas ED, Nathan DG, Gale RP, Kopecky KJ, Rappeport JM, Santos G, GordonSmith EC, Storb R (1979) A prospective study of androgens and bone marrow transplantation for treatment of severe aplastic anemia. Blood 53:504-514 Champlin RE, Ho WG, Feig SA, Winston DJ, Lenarsky C, Gale RP (1985) Do androgens enhance the response to antithymocyte globulin in patients with aplastic anemia? A prospective randomized trial. Blood 66:184-188 Chan PCK, Wei DCC, Tam SCF, Chan FL, Yeung WC, Cheng IKP (1992) Post-transplant erythrocytosis: role of erythropoietin and male sex hormones. Nephrol Dial Transpl 7: 137-142

Chemes HE (2001) Infancy is not a quiescent period of testicular development. Int J Androl 24:2-7

Chlebowski RT, Herrold J, Ali I, Oktay E, Chlebowski JS, Ponce AT, Heber D, Block JB (1986) Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer. Cancer 58:183-186

Cicardi M, Castelli R, Zingale LC, Agostoni A (1997) Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 99:194-196 Cistulli PA, Grunstein RR, Sullivan CE (1994) Effect of testosterone administration on upper airway collapsibility during sleep. Am J Resp Crit Care Med 149:530-532

Conway AJ, Boylan LM, Howe C, Ross G, Handelsman DJ (1988) A randomised clinical trial of testosterone replacement therapy in hypogonadal men. Int J Androl 11:247-264 Coodley GO, Coodley MK (1997) A trial of testosterone therapy for HIV-associated weight loss. AIDS 11:1347-1352

Cooperative Group for the Study of Aplastic and Refractory Anaemias (1979) Androgen therapy of aplastic anemia: a prospective study of 352 cases. Scand J Haematol 22:343-356 Copenhagen Study Group for Liver Diseases (1986) Testosterone treatment of men with alcoholic cirrhosis: a double-blind study. Hepatology 6:807-813 Crawford BA, Liu PY, Kean M, Bleasel J, Handelsman DJ (2003) Randomised, placebo-controlled trial of androgen effects on bone and muscle in men requiring long-term systemic glucocorticoid therapy. J Clin Endocrinol Metab 88:3167-3176 Crawford BA, Spaliviero JA, Simpson JM, Handelsman DJ (1998) Testing the gonadal regression-

cytoprotection hypothesis. Cancer Res 58:5105-5109 Cutolo M, Balleari E, Giusti M, Intra E, Accardo S (1991) Androgen replacement therapy in male patients with rheumatoid arthritis. Arthritis Rheum 34:1-5 da Cunha MF, Meistrich ML, Nader S (1987) Absence of protection by a GnRH analogue against cyclophosphamide induced testicular cytotoxicity in the mouse. Cancer Res 47: 1093-1097

Darnton SJ, Zgainski B, Grenier I, Allister K, Hiller L, McManus KG, Steyn RS (1999) The use of an anabolic steroid (nandrolone decanoate) to improve nutritional status after esophageal resection for carcinoma. Dis Esophagus 12:283-288 Demling RH (1999) Comparison of the anabolic effects and complications of human growth hormone and the testosterone analog, oxandrolone, after severe burn injury. Burns 25: 215-221

Demling RH, DeSanti L (1997) Oxandrolone, an anabolic steroid, significantly increases the rate of weight gain in the recovery phase after major burns. J Trauma 43:47-51 Demling RH, DeSanti L (2001) The rate of restoration of body weight after burn injury, using the anabolic agent oxandrolone, is not age dependent. Burns 27:46-51 Demling RH, Orgill DP (2000) The anticatabolic and wound healing effects of the testosterone analog oxandrolone after severe burn injury. J Crit Care 15:12-17 Dobs AS, Cofrancesco J, Nolten WE, Danoff A, Anderson R, Hamilton CD, Feinberg J, Seekins D, Yangco B, Rhame F (1999) The use of a transscrotal testosterone delivery system in the treatment of patients with weight loss related to human immunodeficiency virus infection. Am J Med 107:126-132

Dontas AS, Papanicolaou NT, Papanayiotou P, Malamos BK (1967) Long-term effects of anabolic steroids on renal functions in the aged subject. J Gerontol 22:268-273 Drinka PJ, Jochen AL, Cuisinier M, Bloom R, Rudman I, Rudman D (1995) Polycythemia as a complication oftestosterone replacement therapy in nursing home men with low testosterone levels. J Am Geriatr Soc 43:899-901 Drosos AA, van Vliet-Dascalopoulos E, Andonopoulos AP, Galanopoulou V, Skopouli FN, Moutsopoulos HM (1988) Nandrolone decanoate (deca-durabolin) in primary Sjogren's syndrome: a double blind study. Clin Exp Rheumatol 6:53-57

El-Sadr A, Sabry AA, Abdel-Rahman M, El-Barnachawy R, Koraitim M (1990) Treatment of primary nocturnal enuresis by oral androgen mesterolone. A clinical and cystometric study. Urology 36:331-335

Evans JT, Elias EG (1972) The erythropoietic response to anabolic therapy in patients receiving radiotherapy. J Clin Pharmacol New Drugs 12:101-104 Fairfield WP, Treat M, Rosenthal DI, Frontera W, Stanley T, Corcoran C, Costello M, Parlman K, Schoenfeld D, Klibanski A, Grinspoon S (2001) Effects of testosterone and exercise on muscle leanness in eugonadal men with AIDS wasting. J Appl Physiol 90:2166-2171 Fenichel G, Pestronk A, Florence J, Robison V, Hemelt VM (1997) A beneficial effect of oxandrolone in the treatment of Duchenne muscular dystrophy: a pilot study. Neurology 48:12251226

Fenichel GM, Griggs RC, Kissel J, Kramer TI, Mendell JR, Moxley RT, Pestronk A, Sheng K, Florence J, King WM, Pandya S, Robison VD, Wang H (2001) A randomized efficacy and safety trial of oxandrolone in the treatment of Duchenne dystrophy. Neurology 56: 1075-1079

Fenster LF (1966) The nonefficacy of short-term anabolic steroid therapy in alcoholic liver disease.

Ann Intern Med 65:738-744 Ferreira IM, Verreschi IT, Nery LE, Goldstein RS, Zamel N, Brooks D, Jardim JR (1998) The influence of 6 months of oral anabolic steroids on body mass and respiratory muscles in undernourished COPD patients. Chest 114:19-28 Foss GL (1939) Clinical administration of androgens. Lancet: 502-504

Franke WW, Berendonk B (1997) Hormonal doping and androgenization of athletes: a secret program of the German Democratic Republic government. Clin Chem 43:1262-1279 French Cooperative Group for the Study of Aplastic and Refractory Anaemias (1986) Androgen therapy in aplastic anemia: a comparative study of high and low-doses and of 4 different androgens. Scand J Haematol 36:346-352 Gascon A, Belvis JJ, Berisa F, Iglesias E, Estopinan V, Teruel JL (1999) Nandrolone decanoate is a good alternative for the treatment of anemia in elderly male patients on hemodialysis. Geriat Nephrol Urol 9:67-72

Gaughan WJ, Liss KA, Dunn SR, Mangold AM, Buhsmer JP, Michael B, Burke JF (1997) A 6-month study of low-dose recombinant human erythropoietin alone and in combination with androgens for the treatment of anemia in chronic hemodialysis patients. Am J Kidney Dis 30:495-500

Gelfand JA, Sherins RJ, Alling DW, Frank MM (1976) Treatment of hereditary angioedema with danazol: reversal of clinical and biochemical abnormalities. N Engl J Med 295:1444-1448 Gelfand MM, Wiita B (1997) Androgen and estrogen-androgen hormone replacement therapy:

a review of the safety literature, 1941 to 1996. Clin Ther 19:383-404; discussion 367-368 Gervasio JM, Dickerson RN, Swearingen J, Yates ME, Yuen C, Fabian TC, Croce MA, Brown RO

(2000) Oxandrolone in trauma patients. Pharmacotherapy 20:1328-1334 Gitlin N, Korner P, Yang HM (1999) Liver function in postmenopausal women on estrogen-androgen hormone replacement therapy: a meta-analysis of eight clinical trials. Menopause 6:216-224

Glode LM, Robinson J, Gould SF (1981) Protection from cyclophosphamide-induced testicular damage with an analogue of gonadotrophin-releasing hormone. Lancet 1:11321134

Gluud C, Bennett P, Dietrichson O, Johnsen SG, Ranek L, Svendsen LB, Juhl E (1981) Short-term parenteral and peroral testosterone administration in men with alcoholic cirrhosis. Scand J Gastroentero 16:749-755 Gluud C, Bennett P, Svenstrup B, Micic S, Copenhagen Study Group for Liver Diseases (1988a) Effect of oral testosterone treatment on serum concentrations of sex steroids, gonadotrophins and prolactin in alcoholic cirrhotic men. Aliment Pharmacol Ther 2:119-128 Gluud C, Christoffersen P, Eriksen J, Wantzin P, Knudsen BB, Copenhagen Study Group for Liver Diseases (1987a) No effect of long-term oral testosterone treatment on liver morphology in men with alcoholic cirrhosis. Am J Gastroenterol 82:660-664 Gluud C, Dejgard A, Bennett P, Svenstrup B (1987b) Androgens and oestrogens before and following oral testosterone administration in male patients with and without alcoholic cirrhosis. Acta Endocrinol 115:385-391 Gluud C, Henricksen JH, Copenhagen Study Group for Liver Diseases (1987c) Liver hemodynamics and function in alcoholic cirrhosis. J Hepatol 4:168-173 Gluud C, Wantzin P, Eriksen J, Copenhagen Study Group for Liver Diseases (1988b) No effect of oral testosterone treatment on sexual dysfunction in alcoholic cirrhotic men. Gastroenterology 95:1582-1587

Griggs RC, Kingston W, Herr BE, Forbes G, Moxley RT (1985) Lack of relationship of hypogonadism to muscle wasting in myotonic dystrophy. Arch Neurol 42:881-885 Griggs RC, Pandya S, Florence JM, Brooke MH, Kingston W, Miller JP, Chutkow J, Herr BE, Moxley RT (1989) Randomized controlled trial of testosterone in myotonic dystrophy. Neurology 39:219-222

Grimaldi C, Bleiberg H, Gay F, Messner M, Rougier P, Kok TC, Cirera L, Cervantes A, De Greve J, Paillot B, Buset M, Nitti D, Sahmoud T, Duez N, Wils J (1998) Evaluation of antiandro-gen therapy in unresectable hepatocellular carcinoma: results of a European Organization for Research and Treatment of Cancer multicentric double-blind trial. J Clin Oncol 16:411417

Grinspoon S, Corcoran C, Anderson E, Hubbard J, Stanley T, Basgoz N, Klibanski A (1999) Sustained anabolic effects of long-term androgen administration in men with AIDS wasting. Clin Infect Dis 28:634-636 Grinspoon S, Corcoran C, Askari H, Schoenfeld D, Wolf L, Burrows B, Walsh M, Hayden D, Parlman K, Anderson E, Basgoz N, Klibanski A (1998) Effects of androgen administration in men with the AIDS wasting syndrome. A randomized, double-blind, placebo-controlled trial. Ann Intern Med 129:18-26 Grinspoon S, Corcoran C, Parlman K, Costello M, Rosenthal D, Anderson E, Stanley T, Schoenfeld D, Burrows B, Hayden D, Basgoz N, Klibanski A (2000) Effects of testosterone and progressive resistance training in eugonadal men with AIDS wasting. A randomized, controlled trial. Ann Intern Med 133:348-355 Grunfeld C, Feingold KR (1992) Metabolic disturbances and wasting in the Acquired Immunodeficiency Syndrome. N Engl J Med 327:329-337

Grunstein RR, Handelsman DJ, Lawrence SJ, Blackwell C, Caterson ID, Sullivan CE (1989) Hypothalamic dysfunction in sleep apnea: reversal by nasal continuous positive airways pressure. J Clin Endocrinol Metab 68:352-358 Hajjar RR, Kaiser FE, Morley JE (1997) Outcomes of long-term testosterone replacement in older hypogonadal males: a retrospective analysis. J Clin Endocrinol Metab 82:3793-3796 Hall GM, Larbre JP, Spector TD, Perry LA, Silva JAD (1996) A randomized trial of testosterone therapy in males with rheumatoid arthritis. Br J Rheumatol 35:568-573 Hamdy RC, Moore SW, Whalen KE, Landy C (1998) Nandrolone decanoate for men with osteoporosis. Am J Ther 5:89-95 Hamilton JB (1937) Treatment of sexual underdevelopment with synthetic male hormone substance. Endocrinology 21:649-654 Handelsman DJ (1985) Hypothalamic-pituitary gonadal dysfunction in chronic renal failure, dialysis, and renal transplantation. Endocr Rev 6:151-182 Handelsman DJ. Testicular dysfunction in systemic diseases. In: Nieschlag E, Behre HM (eds) Andrology: Male reproductive health and dysfunction, 2nd ed, Springer-Verlag, Berlin, 2001, pp 241-251

Handelsman DJ, Dong Q (1993) Hypothalamo-pituitary gonadal axis in chronic renal failure.

Endocrinol Metab Clin North Am 22:145-161 Handelsman DJ, Liu PY (1998) Androgen therapy in chronic renal failure. Bailliere Clin Endoc 12:485-500

Handelsman DJ, Mackey MA, Howe C, Turner L, Conway AJ (1997) Analysis of testosterone implants for androgen replacement therapy. Clin Endocrinol (Oxf) 47:311-316 Hansell DT, Davies JW, Shenkin A, Garden OJ, Burns HJ, Carter DC (1989) The effects of an anabolic steroid and peripherally administered intravenous nutrition in the early postoperative period. J Pen. J Parenter Enteral Nutr 13:349-358 Hausmann DF, Nutz V, Rommelsheim K, Caspari R, Mosebach KO (1990) Anabolic steroids in polytrauma patients. Influence on renal nitrogen and amino acid losses: a double-blind study. J Pen. J Parenter Enteral Nutr 14:111-114 Hazelton RA, McCruden AB, Sturrock RD, Stimson WH (1983) Hormonal manipulation of the immune response in systemic lupus erythematosus: a drug trial of an anabolic steroid, 19-nortestosterone. Ann Rheum Dis 42:155-157 Hendler ED, Goffinet JA, Ross S, Longnecker RE, Bakovic V (1974) Controlled study of androgen therapy in anemia of patients on maintenance hemodialysis. N Engl J Med 291:10461051

Honkanen L, Lesser GT (2001) Testosterone use for rehabilitation of older men. J Am Geriatr Soc 49:339-340

Horl WH (1999) Is there a role for adjuvant therapy in patients being treated with epoetin?

Nephrol Dial Transpl 14:50-60 Hosea SW, Santaella ML, Brown EJ, Berger M, Katusha K, Frank MM (1980) Long-term therapy of hereditary angioedema with danazol. Ann Intern Med 93:809-812 Howell SJ, Radford JA, Adams JE, Smets EM, Warburton R, Shalet SM (2001) Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy. Clin Endocrinol (Oxf) 55:315-324

Howell SJ, Radford JA, Smets EM, Shalet SM (2000) Fatigue, sexual function and mood following treatment for hematological malignancy: the impact of mild Ley dig cell dysfunction. Br J Cancer 82:789-793

Inkovaara J, Gothoni G, Halttula R, Heikinheimo R, Tokola O (1983) Calcium, vitamin D and anabolic steroid in treatment ofaged bones: double-blind placebo-controlled long-term clinical trial. Age Ageing 12:124-130 Ishak KG, Zimmerman HJ (1987) Hepatotoxic effects ofthe anabolic-androgenic steroids. Semin Liver Dis 7:230-236

Itil TM, Cora R, Akpinar S, Herrmann WM, Patterson CJ (1974) "Psychotropic" action of sex hormones: computerized EEG in establishing the immediate CNS effects of steroid hormones. Current Ther Res 16:1147-1170 Itil TM, Michael ST, Shapiro DM, Itil KZ (1984) The effects of mesterolone, a male sex hormone in depressed patients: a double blind controlled study. Methods Find Exp Clin Pharmacol 6:331-337

Jayson MI, Holland CD, Keegan A, Illingworth K, Taylor L (1991) A controlled study of stanozolol in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis 50:41-47 Jockenhovel F, Vogel E, Reinhardt W, Reinwein D (1997) Effects of various modes of androgen substitution therapy on erythropoiesis. Eur J Med Res 2:293-298 Johansen KL, Mulligan K, Schambelan M (1999) Anabolic effects of nandrolone decanoate in patients receiving dialysis: a randomized controlled trial. JAMA 281:1275-1281 Johnson DH, Linde R, Hainsworth JD, Vale W, Rivier J, Stein R, Flexner J, van Welch R, Greco FA (1985) Effect of a luteinizing hormone releasing hormone agonist given during combination chemotherapy on post-therapy fertility in male patients with lymphoma: preliminary observations. Blood 65:832-836 Joura EA, Zeisler H, Bancher-Todesca D, Sator MO, Schneider B, Gitsch G (1997) Short-term effects of topical testosterone in vulvar lichen sclerosis. Obstet Gynecol 89:297-299 Kaltwasser JP, Dix U, Schalk KP, Vogt H (1998) Effect of androgens on the response to antithy-

mocyte globulin in patients with aplastic anemia. Eur J Hematol 40:111-118 Kamischke A, Kemper DE, Castel MA, Luthke M, Rolf C, Behre HM, Magnussen H, Nieschlag E (1998) Testosterone levels in men with chronic obstructive pulmonary disease with or without glucocorticoid therapy. Eur Respir J 11:41-45 Kassmann K, Rappaport R, Broyer M (1992) The short-term effect of testosterone on growth in boys on hemodialysis. Clin Nephrol 37:148-154 Kelleher S, Wishart SM, Liu PY, Turner L, Di Pierro I, Conway AJ, Handelsman DJ (2001) Long-

term outcomes of elective human sperm cryostorage. Hum Reprod 16:2632-2639 Kennedy BJ, Gilbertsen AS (1957) Increased erythropoiesis induced by androgenic hormone therapy. N Engl J Med 256:719-726 Kerrebijn KF, Delver A (1969) Ethylestrenol (Orgabolin): effects on asthmatic children during corticosteroid treatment. Scand J Respir Dis 68:70-77 Kimmel PL, Miller G, Mendelson WB (1989) Sleep apnea syndrome in chronic renal disease. Am J Med 86:308-314

Kopera H. Miscellaneous uses of anabolic steroids. In: Kochakian CD (ed) Anabolic-androgenic steroids, Springer-Verlag, Berlin, 1976, pp 535-625

Kotler DP, Tierney AR, Wang J, Pierson RN (1989) Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr 50:444-447 Krauss DJ, Taub HA, Lantinga LJ, Dunsky MH, Kelly CM (1991) Risks of blood volume changes in hypogonadal men treated with testosterone enanthate for erectile impotence. J Urol 146: 1566-1570

KreusserED, Hetzel WD, Hautmann R, Pfeiffer EF (1990) Reproductive toxicity withandwithout LHRHa administration during adjuvant chemotherapy in patients with germ cell tumors. Horm Metab Res 22:494-498 Kruskemper HL. Anabolic Steroids. New York: Academic Press, 1968

Lahita RG, Cheng CY, Monder C, Bardin CW (1992) Experience with 19-nortestosterone in the therapy of systemic lupus erythematosus: worsened disease after treatment with 19-nortestosterone in men and lack ofimprovement in women. J Rheumatol 19:547-555 Leibenluft E, Schmidt PJ, Turner EH, Danaceau MA, Ashman SB, Wehr TA, Rubinow DR (1997) Effects ofleuprolide-induced hypogonadism and testosterone replacement on sleep, melatonin, and prolactin secretion in men. J Clin Endocrinol Metab 82:3203-3207 Lewis L, Dahn M, Kirkpatrick JR (1981) Anabolic steroid administration during nutritional support: a therapeutic controvery. J Pen. J Parenter Enteral Nutr 5:64-66 Li Bock E, Fulle HH, Heimpel H, Pribilla W (1976) Die Wirkung von Mesterolon bei

Panmyelopathien und renalen Anaemien. Med Klin 71:539-547 Lijesen GK, Theeuwen I, Assendelft WJ, Van Der Wal G (1995) The effect of human chorionic gonadotropin (HCG) in the treatment of obesity by means of the Simeons therapy: a criteria-based meta-analysis. Br J Clin Pharmacol 40:237-243 Liu PY, Death AK, Handelsman DJ (2003a) Androgens and cardiovascular disease. Endocr Rev 24:313-340

Liu PY, Yee BJ, Wishart SM, Jimenez M, Jung DG, Grunstein RR, Handelsman DJ (2003b) The short-term effects of high dose testosterone on sleep, breathing and function in older men. J Clin Endocrinol Metab 88:3605-3613 Loprinzi CL, Kugler JW, Sloan JA, Mailliard JA, Krook JE, Wilwerding MB, Rowland KM, Jr., Camoriano JK, Novotny PJ, Christensen BJ (1999) Randomized comparison of mege-strol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia. J Clin Oncol 17:3299-3306 Lovejoy JC, Bray GA, Greeson CS, Klemperer M, Morris J, Partington C, Tulley R (1995) Oral anabolic steroid treatment, but not parenteral androgen treatment, decreases abdominal fat in obese, older men. Int J Obes 19:614-624 Maddrey WC (1986) Is therapy with testosterone or anabolic-androgenic steroids useful in the treatment of alcoholic liver disease? Hepatology 6:1033-1035 Mandelli F, Amadori S, Dini E, Grignani F, Leoni P, Liso V, Martelli M, Neri A, Petti MC, Ferrini PR (1981) Randomized clinical trial of immunotherapy and androgenotherapy for remission maintenance in acute non-lymphocytic leukemia. Leuk Res 5:447-452 Marin P (1995) Testosterone and regional fat distribution. Obes Res 3 Suppl 4:609S-612S Marin P, Holmang S, Jonsson L, Sjostrom L, Kvist H, Holm G, Lindstedt G, Bjorntorp P (1992) The effects of testosterone treatment on body composition and metabolism in middle-aged obese men. Int J Obes 16:991-997

Marin P, Oden B, Bjorntorp P (1995) Assimilation and mobilization of triglycerides in subcutaneous abdominal and femoral adipose tissue in vivo in men: effects of androgens. J Clin Endocrinol Metab 80:239-243 Masala A, Faedda R, Magna A, Satta A, Chiarelli G, Rovasio PP, Ivaldi R, Taras MS, Lai E, Bartoli E (1997) Use of testosterone to prevent cyclophosphamide-induced azoospermia. Ann Intern Med 126:292-295

Matsumoto A, Sandblom RE, Schoene RB, Lee KA, Giblin EC, Pierson DJ, Bremner WJ (1985) Testosterone replacement in hypogonadal men: effects on obstructive sleep apnea, respiratory drives and sleep. Clin Endocrinol (Oxf) 22:713-721 McMullin GM, Watkin GT, Coleridge Smith PD, Scurr JH (1991) Efficacy of fibrinolytic enhancement with stanozolol in the treatment of venous insufficiency. Aust NZ J Surg 61:306-309 Meikle AW, Arver S, Dobs AS, Sanders SW, Rajaram L, Mazer NA (1996) Pharmacokinetics and metabolism of a permeation-enhanced testosterone transdermal system in hypogonadal men: influence of application site- a clinical research center study. J Clin Endocrinol Metab 81:1832-1840

Meistrick ML (1993) Effects of chemotherapy and radiotherapy on spermatogenesis. Eur Urol 23:136-141

Mendenhall CL, Anderson S, Garcia-Pont P, Goldberg S, Kiernan T, Seeff LB, Sorrell M, Tamburro C, Weesner R, Zetterman R, Chedid A, Chen T, Rabin L, Veterans Administration Cooperative Study on Alcoholic Hepatitis (1984) Short-term and long-term survival in patients with alcoholic hepatitis treated with oxandrolone and prenisolone. N Engl J Med 311:14641470

Mendenhall CL, Moritz TE, Roselle GA, Morgan TR, Nemchausky BA, Tamburro CH, Schiff ER, McClain CJ, Marsano LS, Allen JI (1993) A study of oral nutritional support with oxandrolone in malnourished patients with alcoholic hepatitis. Hepatology 17:564-576 Millman RP, Kimmel PL, Shore ET, Wasserstein AG (1985) Sleep apnea in hemodialysis patients:

the lack of testosterone effect on its pathogenesis. Nephron 40:407-410 Mooradian AD, Morley JE, Korenman SG (1987) Biological actions of androgens. Endocr Rev 8:1-28

Morley JE, Perry HM, Kaiser FE, Kraengle D, Jensen J, Houston K, Mattammal M, Perry HM (1993) Effects of testosterone replacement therapy in old hypogonadal males: a preliminary study. J Am Geriatr Soc 41:149-152 Morris ID (1993) Protection against cytotoxic-induced testis damage - experimental approaches. Eur Urol 23:143-147

Muller V, Szabo A, Viklicky O, Gaul I, Portl S, Philipp T, Heemann UW (1999) Sex hormones and gender-related differences: their influence on chronic renal allograft rejection. Kidney Int 55:2011-2020

Nagasue N, Yu L, Yukaya H, Kohno H, Nakamura T (1995) Androgen and oestrogen receptors in hepatocellular carcinoma and surrounding liver parenchyma: impact on intrahepatic recurrence after hepatic resection. Br J Surg 82:542-547 Naik RB, Gibbons AR, Gyde OH, Harris BR, Robinson BH (1978) Androgen trial in renal anemia. Proc Eur Dial Transplant Assoc 15:136-143

Nejean Y, Joint Group for the Study of Aplastic and Refractory Anaemias (1981) Long-term follow-up in patients with aplastic anemia. A study of 137 androgen-treated patients surviving more than two years. Am J Med 71:543-551 Najean Y, Pecking A (1979) Refractory anemia with excess of blast cells: prognostic factors and effect of treatment with androgens or cytosine arabinoside. Results of a prospective trial in 58 patients. Cooperative Group for the Study of Aplastic and Refractory Anaemias. Cancer 44:1976-1982

Navarro JF, Mora C (2001) In-depth review effect of androgens on anemia and malnutrition in renal failure: implications for patients on peritoneal dialysis. Perit Dial Int 21:14-24 Navarro JF, Mora C, Macia M, Garcia J (2002) Randomized prospective comparison between erythropoietin and androgens in CAPD patients. Kidney Int 61:1537-1544 Neff MS, Goldberg J, Slifkin RF, Eiser AR, Calamia V, Kaplan M, Baez A, Gupta S, Mattoo N (1981) A comparison of androgens for anemia in patients on hemodialysis. N Engl J Med 304:871-875

Neff MS, Goldberg J, Slifkin RF, Eiser AR, Calamia V, Kaplan M, Baez A, Gupta S, Mattoo N

(1985) Anemia in chronic renal failure. Acta Endocrinol suppl 271:80-86 Nicolodi M, Sicuteri F, Poggioni M (1993a) Hypothalamic modulation of nociception and reproduction in cluster headache. I. Therapeutic trials ofleuprolide. Cephalgia 13:253-257 Nicolodi M, Sicuteri F, Poggioni M (1993b) Hypothalamic modulation of nociception and reproduction in cluster headache II. Testosterone-induced increase of sexual activity in males with cluster headache. Cephalgia 13:258-260 Nieschlag E, Cuppers HJ, Wickings EJ (1977) Influence of sex, testicular development and liver function on the bioavailability of oral testosterone. Eur J Clin Invest 7:145-147 Nieschlag E, Nieschlag S, Behre HM (1993) Lifespan and testosterone. Nature 366:215 Palacios A, Campfield LA, McClure RD, Steiner B, Swerdloff RS (1983) Effect of testosterone enanthate on hematopoesis in normal men. Fertil Steril 40:100-104 Parsad D, Pandhi R, Juneja A (2001) Stanozolol in chronic urticaria: a double blind, placebo controlled trial. J Dermatol 28:299-302 Paslin D (1996) Androgens in the topical treatment of lichen sclerosis. Int J Dermatol 35:298-301 Perry PJ, Yates WR, Williams RD, Andersen AE, MacIndoe JH, Lund BC, Holman TL (2002)

Testosterone therapy in late-life major depression in males. J Clin Psychiatry 63:1096-101 Pope HG, Jr., Cohane GH, Kanayama G, Siegel AJ, Hudson JI (2003) Testosterone gel supplementation for men with refractory depression: a randomized, placebo-controlled trial. Am J Psychiatry 160:105-111

Portier F, Portmann A, Czernichow P, Vascaut L, Devin E, Benhamou D, Cuvelier A, Muir JF (2000) Evaluation of home versus laboratory polysomnography in the diagnosis of sleep apnea syndrome. Am J Respir Crit Care Med 162:814-818 Rabkin JG, Wagner GJ, Rabkin R (1999) Testosterone therapy for human immunodeficiency virus-positive men with and without hypogonadism. J Clin Psychopharmacol 19:19-27 Reid IR, Wattie DJ, Evans MC, Stapleton JP (1996) Testosterone therapy in glucocorticoid-treated men. Arch Intern Med 156:1173-1177 Rittmaster RS (1994) Finasteride. N Engl J Med 330:120-125

Sandblom RE, Matsumoto AM, Scoene RB, Lee KA, Giblin EC, Bremner WJ, Pierson DJ (1983) Obstructive sleep apnea induced by testosterone administration. N Engl J Med 308:508510

Sattler FR, Jaque SV, Schroeder ET, Olson C, Dube MP, Martinez C, Briggs W, Horton R, Azen S (1999) Effects of pharmacological doses of nandrolone decanoate and progressive resistance training in immunodeficient patients infected with human immunodeficiency virus. J Clin Endocrinol Metab 84:1268-1276 Savin RC (1968) The ineffectiveness of testosterone in male pattern baldness. Arch Dermatol 98:512-514

Schlatt S (2002) Germ cell transplantation. Mol Cell Endocrinol 186:163-167

Schneider BK, Pickett CK, Zwillich CW, Weil JV, McDermott MT, Santen RJ, Varano LA, White

DP (1986) Influence oftestosterone on breathing during sleep. J Appl Physiol 61:618-623 Schofield RS, Hill JA, McGinn CJ, Aran da JM (2002) Hormone therapy in men and risk of cardiac allograft rejection. J Heart Lung Transplant 21:493-495 Schols AM, Slangen J, Volovics L, Wouters EF (1998) Weight loss is a reversible factor in the prognosis of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 157: 1791-1797

Schols AM, Soeters PB, Mostert R, Pluymers RJ, Wouters EF (1995) Physiologic effects of nutritional support and anabolic steroids in patients with chronic obstructive pulmonary disease. A placebo-controlled randomized trial. Am J Respir Crit Care Med 152:1268-1274 Seidman SN, Araujo AB, Roose SP, Davanand DP, Xie S, Cooper TB, McKinlay JB (2002) Low testosterone levels in elderly men with dysthymic disorder. Am J Psychiatry 159:456459

Seidman SN, Araujo AB, Roose SP, McKinlay JB (2001a) Testosterone level, androgen receptor polymorphism, and depressive symptoms in middle-aged men. Biol Psychiatry 50:371376

Seidman SN, Rabkin JG (1998) Testosterone replacement therapy for hypogonadal men with

SSRI-refractory depression. J Affect Disord 48:157-161 Seidman SN, Spatz E, Rizzo C, Roose SP (2001b) Testosterone replacement therapy for hypo-gonadal men with major depressive disorder: a randomized, placebo-controlled clinical trial. J Clin Psychiatry 62:406-412 Shalet SM, Beardwell CG, Jacobs HS, Pearson D (1978) Testicular function following irradiation of the human prepubertal testis. Clin Endocrinol (Oxf) 9:483-490 Sheffer AL, Fearon DT, Austen KF (1977) Methyltestosterone therapy in hereditary angioedema.

Ann Intern Med 86:306-308 Shetty G, Wilson G, Huhtaniemi I, Shuttlesworth GA, Reissmann T, Meistrich ML (2000) Gonadotropin-releasing hormone analogs stimulate and testosterone inhibits the recovery of spermatogenesis in irradiated rats. Endocrinology 141:1735-1745 Sih R, Morley JE, Kaiser FE, Perry HM, 3rd, Patrick P, Ross C (1997) Testosterone replacement in older hypogonadal men: a 12-month randomized controlled trial. J Clin Endocrinol Metab 82:1661-1667

Simon JA (2001) Safety of estrogen/androgen regimens. J Reprod Med 46:281-290

Singh AB, Norris K, Modi N, Sinha-Hikim I, Shen R, Davidson T, Bhasin S (2001) Pharmacokinetics of a transdermal testosterone system in men with end stage renal disease receiving maintenance hemodialysis and healthy hypogonadal men. J Clin Endocrinol Metab 86:24372445

Snyder PJ, Peachey H, Hannoush P, Berlin JA, Loh L, Lenrow DA, Holmes JH, Dlewati A, Santanna J, Rosen CJ, Strom BL (1999) Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age. J Clin Endocrinol Metab 84:2647-2653 Spaulding WB (1960) Methyltestosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med 53:739-745 Spiers ASD, DeVita SF, Allar MJ, Richards S, Sedranak N (1981) Beneficial effects of an anabolic steroid during cytotoxic chemotherapy for metatstatic cancer. J Med 12:433-446 Stewart DA, Grunstein RR, Berthon-Jones M, Handelsman DJ, Sullivan CE (1992) Androgen blockade does not effect sleep disordered breathing orchemosensitivity in men with obstructive sleep apnea. Am Rev Respir Dis 146:1389-1393 Strawford A, Barbieri T, Van Loan M, Parks E, Catlin D, Barton N, Neese R, Christiansen M, King J, Hellerstein MK (1999) Resistance exercise and supraphysiologic androgen therapy in eugonadal men with HIV-related weight loss: a randomized controlled trial. JAMA 281: 1282-1290

Teruel JL, Aguilera A, Marcen R, Antolin JN, Otero GG, Ortuno J (1996a) Androgen therapy for anemia of chronic renal failure. Scand J Urol Nephrol 30:403-408 Teruel JL, Cano T, Marcen R, Villafruela JJ, Rivera M, Fernandez-Juarez G, Ortuno J (1997) Decrease in the hemoglobin level in hemodialysis patients undergoing antiandrogen therapy. Nephrol Dial Transpl 12:1262-1263 Teruel JL, Marcen R, Navarro JF, Villafruela JJ, Fernandez-Lucas M, Liano F, Ortuno J (1995) Evolution of serum erythropoietin after androgen administration to hemodialysis patients: a prospective study. Nephron 70:282-286 Teruel JL, Marcen R, Navarro-Antolin J, Aguilera A, Fernandez-Juarez G, Ortuno J (1996b) Androgen versus erythropoietin for the treatment of anemia in hemodialyzed patients: a prospective study. J Am Soc Nephrol 7:140-144 Thomson AB, Anderson RA, Irvine DS, Kelnar CJ, Sharpe RM, Wallace WH (2002) Investigation of suppression of the hypothalamic-pituitary-gonadal axis to restore spermatogenesis in azoospermic men treated for childhood cancer. Hum Reprod 17:1715-1723 Tweedle D, Walton C, Johnston IDA (1973) The effect of an anabolic steroid on postoperative nitrogen balance. Br J Clin Pract 27:130-132 van Coevorden A, Stolear JC, Dhaene M, Herweghem JLV, Mockel J (1986) Effect of chronic oral testosterone undecanoate administration on the pituitary-testicular axes of hemodialyzed male patients. Clin Nephrol 26:48-54 Van den Berghe G (2003) Endocrine evaluation of patients with critical illness. Endocrinol Metab

Clin North Am 32:385-410 Van den Berghe G, Baxter RC, Weekers F, Wouters P, Bowers CY, Iranmanesh A, Veldhuis JD, Bouillon R (2002) The combined administration of GH-releasing peptide-2 (GHRP-2), TRH and GnRH to men with prolonged critical illness evokes superior endocrine and metabolic effects compared to treatment with GHRP-2 alone. Clin Endocrinol (Oxf) 56:655669

van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R (2001) Intensive insulin therapy in the surgical intensive care unit. N Engl J Med 345:1359-1367 Van Vollenhoven RF, Engleman EG, McGuire JL (1995) Dehydroepiandrosterone in systemic lupus erythematosus. Arthritis Rheum 38:1826-1831 Victor G, Shanmugasundaram K, Krishnamurthi CA, Rex PM, Nagarajan D (1967) Hemoglobin response to anabolic steroid in iron-deficiency anemia. J Assoc Physicians India 15:177183

Vogel W, Klaiber EL, Broverman DM (1985) A comparison of the antidepressant effects of a synthetic androgen (mesterolone) and amitriptyline in depressed men. J Clin Psychiatry 46:6-8

von Hartitzsch B, Kerr DNS (1976) Response to parenteral iron with and without androgen therapy in patients undergoing regular hemodialysis. Nephron 17:430-438 Watson RN, Bradley MH, Callahan R, Peters BJ, Kory RC (1959) A six-month evaluation of an anabolic drug, norethandrolone, in underweight persons. Am J Med 26:238-248 Wattel E, Cambier N, Caulier MT, Sautiere D, Bauters F, Fenaux P (1994) Androgen therapy in myelodysplastic syndromes with thrombocytopenia: a report on 20 cases. Br J Hematol 87:205-208

Waxman JH, Ahmed R, Smith D, Wrigley PFM, Gregory W, Shalet S, Crowther D, Rees LH, Besser GM, Malpas JS, Lister TA (1987) Failure to preserve fertility in patients with Hodgkin's disease. Cancer Chemoth Pharm 19:159-162 Webb WR, Doyle RS, Howard HS (1960) Relative metabolic effects of calories, protein, and an anabolic steroid (19-nortestosterone) in early postoperative period. Metabolism 9:1047-1057 Weber JP, Walsh PC, Peters CA, Spivak JL (1991) Effect of reversible androgen deprivation on hemoglobin and serum erythropoietin in men. Am J Hematol 36:190-194 Wells R (1960) Prednisolone and testosterone propionate in cirrhosis of the liver: a controlled trial. Lancet:1416-1419

White DP, Schneider BK, Santen RJ, McDermott M, Pickett CK, Zwillich CW, Weil JV (1985) Influence of testosterone on ventilation and chemosensitivity in male subjects. J Appl Physiol 59:1452-1457

Wilkey JL, Barson LJ, Kest L, BragagniA (1960) The effect of testosterone on the azotemic patient:

an intermediary report. J Urol 83:25-29 Williams JS, Stein JH, Ferris TF (1974) Nandrolone decanoate therapy for patients receiving hemodialysis. A controlled study. Arch Intern Med 134:289-292 Winearls CG (1995) Historical review of the use of recombinant human erythropoietin in chronic renal failure. Nephrol Dial Transpl 10 (suppl 2):3-9 Wu FC, von Eckardstein A (2003) Androgens and coronary artery disease. Endocr Rev 24:183217

Wu FCW, Farley TMM, Peregoudov A, Waites GMH, WHO Task Force on Methods for the Regulation of Male Fertility (1996) Effects oftestosterone enanthate in normal men: experience from a multicenter contraceptive efficacy study. Fertil Steril 65:626-636

Young GA, Yule AG, Hill GL (1983) Effects of an anabolic steroid on plasma amino acids, proteins, and body composition in patients receiving intravenous hyperalimentation. J Pen. J Parenter Enteral Nutr 7:221-225

Young N, Griffith P, Brittain E, Elfenbein G, Gardner F, Huang A, Harmon D, Hewlett J, Fay J, Mangan K (1988) A multicenter trial of antithymocyte globulin in aplastic anemia and related diseases. Blood 72:1861-1869 Young RL, Fuchs RJ, Woltjen MJ (1976) Chorionic gonadotropin in weight control. A doubleblind crossover study. JAMA 236:2495-2497 Zawilska K, Tokarz A, Misiak A, Psuja P, Wislawski S, Szymczak P, Meissner J, Karon J, Lewandowski K, Lopaciuk S, Ziemski JM, Sowler J (1990) Nebulised heparin and anabolic steroid in the prevention of postoperative deep venous thrombosis following elective abdominal surgery. Folia Haematologica 117:699-707 Zitzmann M, Nieschlag E (2003) The CAG repeat polymorphism within the androgen receptor gene and maleness. Int J Androl 26:76-83

Invisible Viagara

Invisible Viagara

You are about to discover the "little-known" techniques, tricks and "mind tools" that will show you how to easily "program" your body and mind to produce an instant, rock-hard erection. Learn how to enjoy all of the control, confidence and satisfaction that comes from knowing you can always "rise to the challenge" ... and never have to deal with embarrassment, apologies, shyness or performance anxiety in the bedroom, ever again.

Get My Free Ebook

Post a comment